Kiromic Corporation, Inc. (Kiromic)

Oncology Corporate Profile

HQ Location

4265 San Felipe Street, Ste. 1100
Houston, TX 77027

Company Description

Kiromic exists to create a robust diagnostic and therapeutic program for solid tumors and hematologic malignancies based on its portfolio of patented cancer-associated biomarkers and small molecules. Kiromic aims to develop clinical diagnostic tools for rapid detection of cancer-associated antigens, which may translate into earlier diagnosis and accurate monitoring of response to cancer treatments. Their cancer-associated biomarkers also allow for the design and development of personalized, cancer-specific targeted immunotherapy strategies that may improve patient outcomes and result in less suffering and longer survival times.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
KiroVAX-001dendritic cell vaccineVarious cancer typesI


Recent News Headlines

There are no news items to display